Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Synergetic measures to contain highly transmissible variants of SARS-CoV-2

Hang Su, Yafang Cheng, Christian Witt, Nan Ma, Ulrich Pöschl
doi: https://doi.org/10.1101/2021.11.24.21266824
Hang Su
1Multiphase Chemistry Department, Max Planck Institute for Chemistry, 55128 Mainz, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: yafang.cheng@mpic.de h.su@mpic.de
Yafang Cheng
2Minerva Research Group, Max Planck Institute for Chemistry, 55128 Mainz, Germany
3University of Science and Technology of China, 230036 Hefei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: yafang.cheng@mpic.de h.su@mpic.de
Christian Witt
4Department of Outpatient Pneumology, Charité Universitätsmedizin Berlin, Campus Charité Mitte, Charitéplatz 1, 10117, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nan Ma
5Institute for Environmental and Climate Research, Jinan University, Guangzhou 511443, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ulrich Pöschl
1Multiphase Chemistry Department, Max Planck Institute for Chemistry, 55128 Mainz, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Summary

Background The public and scientific discourse on how to mitigate the COVID-19 pandemic is often focused on the impact of individual protective measures, in particular on vaccination. In view of changing virus variants and conditions, however, it seems not clear if vaccination or any other protective measure alone may suffice to contain the transmission of SARS-CoV-2.

Methods Here, we investigate the effectiveness and synergies of vaccination and non-pharmaceutical interventions like masking, distancing & ventilation, testing & isolation, and contact reduction as a function of compliance in the population. Our new analysis accounts for the practical compliance in the population and for both droplet transmission and aerosol transmission.

Findings For realistic conditions, we find that it would be difficult to contain highly contagious SARS-CoV-2 variants by any individual measure. Instead, we show how multiple synergetic measures have to be combined to reduce the effective reproduction number (Re) below unity for different basic reproduction numbers ranging from the SARS-CoV-2 ancestral strain up to measles-like values (R0 = 3 to 18). For R0 = 5 as reported for the Delta variant and ∼70% vaccination rate, the synergies of masking and distancing & ventilation with compliances around 30% appear sufficient to keep Re < 1. In combination with 2-3 tests per week, this would work also at lower vaccination rates, e.g., in schools.

Interpretation If the Omicron variant were to reach R0 = 8, it could still be contained with the synergetic measures outlined above. In case of measles-like transmissibilities (R0 = 12 to 18), higher compliances and testing rates or additional measures like general contact reductions would be required. The presented findings and approach can be used to design and communicate efficient strategies for mitigating the COVID-19 pandemic.

Funding Max Planck Society.

Evidence before this study Studies on how to mitigate the COVID-19 pandemic are often focused on the impact of individual protective measures, in particular on vaccination. The effectiveness of non-pharmaceutical interventions (NPIs) like masking or distancing & ventilation are often under debate due to a lack of understanding of different transmission pathways (droplet versus aerosol transmission) and protective measures, in particular for the efficacy of masking and contrasting randomized trial results under different conditions (virus-limited vs. virus-rich) and at different levels of practical compliance. Thus, in view of more contagious variants such as Delta or Omicron, it is not clear if vaccination or any other protective measure alone may suffice to contain the transmission of SARS-CoV-2.

Added value of this study Our analysis explicitly accounts for both droplet and aerosol transmission as well as for practical compliance in the population, which is the main reason for divergent results on the effectiveness of the same NPIs in different regions. This was not fully considered before and may have led to misunderstandings and misinformation about the actual effects of preventive measures. For realistic conditions, we find that it would be difficult to contain highly contagious SARS-CoV-2 variants by any individual measure. Instead, we show that combining multiple synergetic measures with realistic compliances can reduce Re below unity without lockdown.

Implications of all the available evidence Our findings and the presented scientific approach can be used to design and communicate efficient strategies for mitigating the COVID-19 pandemic for specific environments like schools as well as on a population level.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by the Max Planck Society.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • We have included results relevant for more contagious variants such as Omicron or those of measles-like transmissibilities.

Data Availability

All data produced in the present study are available upon reasonable request to the authors once the manuscript is published in peer-review journals.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted December 23, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Synergetic measures to contain highly transmissible variants of SARS-CoV-2
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Synergetic measures to contain highly transmissible variants of SARS-CoV-2
Hang Su, Yafang Cheng, Christian Witt, Nan Ma, Ulrich Pöschl
medRxiv 2021.11.24.21266824; doi: https://doi.org/10.1101/2021.11.24.21266824
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Synergetic measures to contain highly transmissible variants of SARS-CoV-2
Hang Su, Yafang Cheng, Christian Witt, Nan Ma, Ulrich Pöschl
medRxiv 2021.11.24.21266824; doi: https://doi.org/10.1101/2021.11.24.21266824

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (217)
  • Allergy and Immunology (496)
  • Anesthesia (106)
  • Cardiovascular Medicine (1112)
  • Dentistry and Oral Medicine (197)
  • Dermatology (141)
  • Emergency Medicine (275)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (508)
  • Epidemiology (9807)
  • Forensic Medicine (5)
  • Gastroenterology (482)
  • Genetic and Genomic Medicine (2335)
  • Geriatric Medicine (223)
  • Health Economics (464)
  • Health Informatics (1569)
  • Health Policy (738)
  • Health Systems and Quality Improvement (609)
  • Hematology (238)
  • HIV/AIDS (508)
  • Infectious Diseases (except HIV/AIDS) (11674)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (240)
  • Medical Ethics (67)
  • Nephrology (258)
  • Neurology (2162)
  • Nursing (134)
  • Nutrition (340)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (520)
  • Oncology (1187)
  • Ophthalmology (366)
  • Orthopedics (129)
  • Otolaryngology (221)
  • Pain Medicine (148)
  • Palliative Medicine (50)
  • Pathology (314)
  • Pediatrics (700)
  • Pharmacology and Therapeutics (303)
  • Primary Care Research (268)
  • Psychiatry and Clinical Psychology (2196)
  • Public and Global Health (4694)
  • Radiology and Imaging (786)
  • Rehabilitation Medicine and Physical Therapy (459)
  • Respiratory Medicine (625)
  • Rheumatology (276)
  • Sexual and Reproductive Health (227)
  • Sports Medicine (214)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)